DSKA Insider Trading Activity and SEC Form 4 Filings
DSKA insider trading summary
No open-market insider purchases or sales of Duska Therapeutics, Inc. (DSKA) have been reported on SEC Form 4 in the past 12 months.
Latest DSKA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 3, 2008 | James S Kuo | Chief Executive Officer | Buy | $310 (1,000 @ $0.31) |
| Aug 27, 2008 | James S Kuo | Chief Executive Officer | Buy | $600 (2,000 @ $0.30) |
| Aug 25, 2008 | James S Kuo | Chief Executive Officer | Buy | $180 (900 @ $0.20) |
| Mar 7, 2008 | Hugh David Coherd | Director | Buy | $2K (3,853 @ $0.55) |
| Mar 4, 2008 | Manuel Graiwer | Director | Buy | $8K (14,749 @ $0.55) |
| Dec 6, 2007 | James S Kuo | Chief Executive Officer | Buy | $550 (1,000 @ $0.55) |
| Apr 10, 2007 | Manuel Graiwer | Director | Buy | $17K (57,217 @ $0.30) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.